AlphAIAlphAI — Financial news for AI agents
StockNASDAQ · US · USDHealthcare · Biotechnology

$KARD

Kardigan, Inc.

Price · $KARDvia TradingView
AI sentiment · 7d1 articles
SEP 27net (bullish − bearish)OCT 3
Bullish
0
Neutral
1
Bearish
0
Insider · 30dAll trades →

No SEC Form 4 filings for $KARD in the last 30 days.

See all $KARD insider activity →
Top stories · $KARDMore →
SEP 30·SEC EDGAR 8-KLow

Kardigan, Inc. (KARD): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Kardigan, Inc. (KARD) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 PRESS RELEASE Kardigan Announces Appointment of Kristin Reinke to its Board of Directors SOUTH SAN FRANCISCO, Calif., and PRINCETON, N.J., September 30, 2026 — Kardigan™, Inc. (Nasdaq: KARD) (“Kardigan”), a precision cardiovascular company, announced today the appoin

AUG 11·SEC EDGAR 8-K

Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates

Kardigan, Inc. (KARD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PRESS RELEASE Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates Continued to advance the development of three late-stage programs, supported by the Prolaio platform, aimed at addressing cardiovascular diseases where no approved treatm

KARD sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning KARD (Kardigan, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent KARD coverage spans insider activity, corporate actions and earnings.

What's driving KARD

  • Board change may be viewed as a modest positive for governance but unlikely to move the stock materially.

    SEC EDGAR 8-K · Sep 30, 2026

  • The filing updates funding runway and advances multiple late-stage cardiovascular programs, setting near-term catalysts for 2027 readouts.

    SEC EDGAR 8-K · Aug 11, 2026

  • Large open-market purchase by a 10% owner via indirect holdings signals continued conviction, but it is not a new operational catalyst.

    SEC EDGAR · Jun 25, 2026

  • Large open-market purchase by a director/10% owner can signal confidence, but it is an insider transaction without new operating fundamentals.

    SEC EDGAR · Jun 24, 2026

  • A large 10% owner open-market purchase via indirect holdings signals incremental bullish positioning, but it’s not a fundamental catalyst like guidance or a deal.

    SEC EDGAR · Jun 24, 2026

AlphAI scores every news story that mentions KARD with an AI model for sentiment and relevance, and aggregates insider trades from Kardigan, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $KARD

Score
SEP 30$KARDLowSEC EDGAR 8-K

Kardigan, Inc. (KARD): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Kardigan, Inc. (KARD) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 PRESS RELEASE Kardigan Announces Appointment of Kristin Reinke to its Board of Directors SOUTH SAN FRANCISCO, Calif., and PRINCETON, N.J., September 30, 2026 — Kardigan™, Inc. (Nasdaq: KARD) (“Kardigan”), a precision cardiovascular company, announced today the appoin

1 min read
AUG 11$KARDMedSEC EDGAR 8-K

Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates

Kardigan, Inc. (KARD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PRESS RELEASE Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates Continued to advance the development of three late-stage programs, supported by the Prolaio platform, aimed at addressing cardiovascular diseases where no approved treatm

6 min read

Related tickers

More in Biotechnology